Pharmaceutical Composition of GLP-1/GLP-2 Dual Agonists

A composition comprising:

• (a) one or more GLP-1/GLP-2 dual agonist comprising general formula A:
• H[Aib]EG-X5-F-X7-SELATILD-[ψ]-QAARDFIAWLI-X28-HKITD (A),
• wherein X5 is T or S;
• X7 is T or S;
• X28 is Q, E, A, H, Y, L, K, R or S and at least one of X5 and X7 is T,
• wherein [ψ] indicates an L or D lysine residue in which an albumin binding moiety is conjugated to the GLP-1/GLP-2 dual agonist, and
• wherein said albumin binding moiety is [K([17-carboxy-heptadecanoyl]-isoGlu)];
• (b) one or more preservative, wherein the one or more preservative is or comprises benzoate, benzalkonium chloride and/or benzyl alcohol;
• and
• (c) phosphate buffer.